Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Versant unveils new autoimmune biotech with $100M fundraise
Granite has raised combined series A and B funds of $100 million, with support from Versant Ventures, Novartis, Forbion and Sanofi.
Gabrielle Masson
Apr 24, 2025 8:00am
Fierce Biotech Fundraising Tracker: Granite, Etiome a & more
Apr 24, 2025 8:00am
Third Rock-backed Merida unveils with $121M for autoimmune plans
Apr 8, 2025 11:03am
Cell therapy biotech bags $102M to fund phase 3 epilepsy plans
Apr 3, 2025 1:22pm
Gene therapy biotech secures $150M for eye disease candidates
Apr 2, 2025 7:30am
Sofinnova closes €165M European biotech acceleration fund
Mar 18, 2025 4:01am
